HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer
| Image |  |
|---|---|
| Description | scientific article published on May 15, 2013 |
| Author/s |
author: Ji-Won Kim Sae-Won Han Seock-Ah Im Tae-You Kim Do-Youn Oh |
| Publication date | May 15, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
http://link.springer.com/content/pdf/10.1007/s00280-013-2174-1.pdf |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |